Medtronic is backing out of a $738 million deal to acquire EOFlow, a maker of a wearable insulin patch. The company revealed it was terminating the deal in a filing with the SEC.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,